← Leaderboards
Rebecca Sutphen
H. Lee Moffitt Cancer Ctr &Res Inst
$5,809,592
Attributed
$5,809,592
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $678.7K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$5,809,592 · 2
By mechanism
R01$5,809,592 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanMalignant Neoplasm Of OvaryEarly DiagnosisDiagnosisMalignant NeoplasmsCancer PatientCommunitiesCase-Control StudiesCommunity SettingBlood SpecimenAttentionBrca1 GeneBaseAmericasCaringClinical CareBreast LumpectomyAcademic Medical CentersCa-125 AntigenAreaCountyCancer RiskBlood TestsCase-Based
Grant awards (12)
Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients$122,930
R01 · FY2018 · CA · contact PI
Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients$678,656
R01 · FY2017 · CA · contact PI
Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients$657,997
R01 · FY2016 · CA · contact PI
Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients$216,572
R01 · FY2015 · CA · contact PI
Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients$578,772
R01 · FY2014 · CA · contact PI
Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients$570,119
R01 · FY2013 · CA · contact PI
Population-Based Analysis of Ovarian Cancer Biomarkers$285,118
R01 · FY2009 · CA · contact PI
Population-Based Analysis of Ovarian Cancer Biomarkers$279,938
R01 · FY2009 · CA · contact PI
Population-Based Analysis of Ovarian Cancer Biomarkers$576,087
R01 · FY2008 · CA · contact PI
Population-Based Analysis of Ovarian Cancer Biomarkers$586,468
R01 · FY2007 · CA · contact PI
Population-Based Analysis of Ovarian Cancer Biomarkers$618,991
R01 · FY2006 · CA · contact PI
Population-Based Analysis of Ovarian Cancer Biomarkers$637,944
R01 · FY2005 · CA